This new drug utilizes the bactericidal properties of taurolidine and the bloodthinning effects of heparin to maintain catheter patency.
Egla Hasimllari, PharmD
Advertisement
Articles by Egla Hasimllari, PharmD
On January 6, 2023, the FDA granted lecanemab-irmb (Leqembi) accelerated approval for treating mild cognitive impairment and mild dementia in patients with Alzheimer disease.
Oteseconazole is a treatment option for those living with a previously unmet medical need.
Advertisement
Latest Updated Articles
Vivjoa Approved for Recurrent Vulvovaginal CandidiasisPublished: August 8th 2022 | Updated:
Advertisement
Advertisement
Trending on Drug Topics
1
Vaccination of 3 Or More Doses Reduces Incidence of COVID-19 Symptoms for Young Adults
2
CVS Pharmacy Acquires Select Rite Aid Assets in 3 States, Accounting for Over 600 Stores
3
Introduction of PCV10 Reduces Pneumococcal Infections for Children
4
Vaccine Hesitancy Rises, Highlighting a Crucial Role for Pharmacists
5
